tunicamycin
differ
effect
glycosyl
two
envelop
glycoprotein
mous
hepat
viru
mhv
coronaviru
unlik
envelop
glycoprotein
virus
transmembran
glycoprotein
el
glycosyl
normal
presenc
tunicamycin
suggest
glycosyl
el
involv
transfer
core
oligosaccharid
dolichol
pyrophosph
intermedi
asparagin
residu
may
occur
olink
glycosyl
serin
threonin
residu
synthesi
peplomer
glycoprotein
readili
detect
presenc
tunicamycin
inhibit
nlink
glycosyl
tunicamycin
either
prevent
synthesi
facilit
degrad
protein
moieti
radiolabel
carbohydr
precursor
borat
gel
electrophoresi
glycopeptid
show
differ
oligosaccharid
side
chain
attach
el
two
coronaviru
envelop
glycoprotein
thu
appear
glycosyl
differ
mechan
tunicamycintr
cell
noninfecti
virion
lack
peplom
form
intracytoplasm
membran
releas
cell
virion
contain
normal
amount
nucleocapsid
protein
glycosyl
el
lack
thu
transmembran
glycoprotein
el
viral
glycoprotein
requir
format
viral
envelop
viru
matur
releas
peplomer
glycoprotein
appear
requir
attach
viru
receptor
plasma
membran
coronaviru
envelop
envelop
glycoprotein
el
appear
novel
type
viral
glycoprotein
posttransl
glycosyl
tunicamycinresist
process
yield
oligosaccharid
side
chain
differ
nlink
glycoprotein
find
suggest
el
may
particularli
use
model
studi
biosynthesi
glycosyl
intracellular
transport
olink
glycoprotein
synthesi
glycosyl
intracellular
transport
glycoprotein
essenti
understand
structur
function
cell
membran
role
oligosaccharid
glycoprotein
process
secret
glycosyl
transport
viral
envelop
glycoprotein
depend
upon
cellular
process
g
glycoprotein
vesicular
stomat
viru
use
excel
model
glycosyl
transport
nlink
glycoprotein
reprint
request
address
man
lodish
rothman
et
morrison
et
al
gibson
et
al
oligosaccharid
may
also
olink
serin
threonin
residu
polypeptid
chain
process
less
well
understood
sharon
li
olink
oligosaccharid
predomin
mani
cell
surfac
glycoprotein
glycophorin
tomita
marchesi
secret
glycoprotein
submaxillari
mucin
slomiani
slomiani
although
tunicamycin
inhibit
glycosyl
nlink
glycoprotein
takatsuki
et
al
lehl
tanner
schwarz
et
al
schwarz
et
al
elbein
schwarz
datema
drug
inhibit
olink
glycosyl
yet
identifi
schwarz
et
al
sharon
li
viral
envelop
glycoprotein
studi
date
nlink
type
glycoprotein
leavitt
et
ok
morrison
et
cd
schwarz
et
al
nakamura
compan
cash
et
pizer
et
al
klenk
rott
choppin
scheid
ghosh
stallcup
field
present
evid
coronaviru
glycoprotein
may
glycosyl
differ
mechan
glycoprotein
may
serv
use
model
studi
olink
glycoprotein
coronavirus
envelop
virus
contain
x
dalton
posit
sens
singlestrand
polyadenyl
rna
tyrrel
et
cd
wege
et
cd
lai
stohlman
macnaughton
et
virus
caus
varieti
respiratori
enter
neurolog
diseas
anim
man
andrew
et
virion
strain
mous
hepat
viru
contain
three
structur
polypeptid
phosphoryl
nucleocapsid
protein
n
two
glycoprotein
el
sever
interest
properti
sturman
sturman
holm
sturman
et
cd
sturman
glycoprotein
form
larg
petalshap
peplom
characterist
coronaviru
envelop
glycoprotein
cleav
trypsin
yield
two
compon
glycoprotein
el
appear
transmembran
molecul
three
domain
glycosyl
domain
project
envelop
second
domain
lie
within
membran
third
domain
appear
interact
nucleocapsid
insid
viral
envelop
unlik
protein
el
boil
presenc
sd
mercaptoethanol
aggreg
dimer
trimer
tetram
intracellular
distribut
el
also
unusu
label
monospecif
fluoresc
antibodi
isol
el
sturman
et
cd
show
el
remain
restrict
perinuclear
area
cell
like
viral
glycoprotein
migrat
rapidli
via
intracellular
membran
plasma
membran
doller
holm
present
studi
use
antibiot
tunicamycin
studi
synthesi
glycosyl
coronaviru
mhv
tunicamycin
analog
udpnacetylglucosamin
interfer
format
dolichol
pyrophosphatehracetylglucosamin
act
carrier
nglycosid
linkag
core
oligosaccharid
asparagin
residu
glycoprotein
tunicamycin
interfer
cotransl
glycosyl
glycoprotein
takatsuki
et
al
lehl
tanner
schwarz
et
al
demonstr
tunicamycin
inhibit
format
glycoprotein
mhv
prevent
synthesi
glycosyl
transmembran
glycoprotein
el
format
virion
releas
virion
cell
evid
indic
uniqu
el
glycoprotein
coronaviru
may
olink
glycoprotein
thu
could
particularli
use
model
studi
synthesi
glycosyl
intracellular
transport
olink
glycoprotein
mammalian
cell
viru
propag
putificatim
strain
mous
hepat
viru
mhv
grown
spontan
transform
cll
line
balbc
mous
fibroblast
previous
describ
sturman
takemoto
sturman
assay
plaqu
titrat
cl
cell
prepar
radiol
viru
cell
plastic
flask
inocul
ml
mhv
multipl
pfucel
dulbecco
modifi
eagl
minim
essenti
medium
high
glucos
dmem
gibco
grand
island
n
incub
hr
inoculum
remov
cell
refe
ml
emem
dialyz
fetal
bovin
serum
dfb
contain
iml
l
rh
amino
acid
mixtur
new
england
nuclear
incub
hr
viru
releas
supernat
medium
harvest
purifi
modif
method
describ
previous
sturman
et
al
use
discontin
continu
sucros
densiti
gradient
tm
buffer
contain
trismal
nacl
ph
omit
polyethylen
glycol
precipit
step
electrophoresi
intracellular
viral
polpeptid
studi
synthesi
process
releas
viral
specif
polypeptid
pulsechas
experi
perform
confluent
monolay
cl
cell
petri
dish
falcon
inc
preincub
hr
lleucin
defici
emem
leudef
mem
dfb
either
mock
infect
mlplate
leudef
mem
dfb
inocul
pfu
mhvcell
mlplate
leudef
mem
dfb
incub
hr
inocula
remov
cell
refe
leudef
mem
dfb
without
pgml
tunicamycin
eli
lilli
indianapoli
ind
cultur
held
four
hour
prior
puls
label
pgml
actinomycin
ad
medium
hr
viru
inocul
infect
control
cell
puls
label
min
ml
new
england
nuclear
inc
label
medium
remov
cell
wash
refe
dmem
contain
lofold
excess
unlabel
lleucin
fb
pgml
tunicamycin
interv
puls
label
intracellular
polypeptid
extract
cell
wash
twice
pb
solubil
mlplate
nonidet
accur
chemic
corp
pb
nuclei
debri
remov
centrifug
q
min
radiolabel
polypeptid
analyz
directli
polyacrylamid
gel
electrophoresi
page
immunoprecipit
rabbit
antiserum
purifi
detergentdisrupt
virion
presenc
staphylococc
protein
prior
analysi
page
sturman
et
al
sampl
sdspage
slab
gel
heat
min
equal
volum
sampl
treatment
mixtur
compos
urea
sd
bromphenol
blue
trischlorid
ph
sdspage
cylindr
gel
perform
use
high
ph
discontinu
buffer
system
fraction
gel
gilson
automat
linear
gel
fraction
previous
describ
sturman
holm
five
twenti
percent
polyacrylamid
gradient
slab
gel
prepar
fluorograph
previous
describ
sturman
et
al
anal
glycopeptid
glycoprotein
el
isol
sdspage
gradientpurifi
mhv
grown
hr
medium
contain
iml
new
england
nuclear
inc
isol
el
elut
gel
digest
pg
selfdigest
pronas
sigma
per
millilit
hr
concentr
lyophil
analyz
borat
ester
page
trisbor
buffer
ph
accord
method
weitzman
et
al
electron
microscopi
concentr
gradientpurifi
virion
prepar
electron
microscopi
use
phosphotungst
acid
pta
ph
carbonco
formvarcov
copper
grid
electron
microscopi
cell
done
fixat
glutaraldehyd
follow
postfix
osmium
tetroxid
dehydr
grade
seri
ethyl
alcohol
solut
propylen
oxid
embed
epon
resin
previous
describ
compan
et
al
section
stain
lead
citrat
uranyl
acet
examin
jeol
electron
microscop
synthesi
process
coronavirusspecif
polypeptid
analyz
pulselabel
techniqu
cell
treat
hr
actinomycin
reduc
cellular
protein
synthesi
without
tunicamycin
puls
label
rh
leucin
hr
viru
inocul
show
synthesi
three
structur
polypeptid
el
n
fig
channel
highmolecularweight
polyprotein
detect
thu
structur
polypeptid
appear
translat
inedpend
also
shown
vitro
translat
studi
isol
mhv
mrna
siddel
et
c
rottier
et
cd
success
chase
period
shift
molecular
weight
nucleocapsid
protein
n
peplomer
glycoprotein
observ
sinc
glycoprotein
known
extens
glycosyl
sturman
sturman
holm
suggest
either
glycosyl
cotransl
event
andor
glycosyl
nonglycosyl
resolv
region
gradient
slab
gel
pulsechas
experi
label
hr
infect
show
el
synthes
speci
chase
broad
band
appar
fig
channel
due
overexposur
doubl
label
studi
intracellular
viral
polypeptid
demonstr
form
el
glycosyl
wherea
speci
label
phlglucosamin
data
shown
antibodi
el
purifi
virion
sucros
densiti
gradient
sediment
immunoprecipit
broad
band
el
sturman
et
cd
similar
pulsechas
radiolabel
studi
perform
cell
infect
mhv
treat
pgml
tunicamycin
label
leucin
fig
channel
synthesi
nonglycosyl
nucleocapsid
protein
n
affect
tunicamycin
synthesi
glycoprotein
detect
presenc
tunicamycin
thu
tunicamycin
either
inhibit
synthesi
facilit
rapid
degrad
newli
synthes
tunicamycin
shown
interfer
synthesi
detect
sever
glycoprotein
cotransl
glycosyl
via
nlink
glycosid
bond
lehl
tanner
leavitt
et
al
olden
et
al
gibson
et
al
stallcup
field
three
polypeptid
molecular
weight
seen
channel
cellular
polypeptid
sinc
also
appear
equal
intens
kinet
uninfect
cell
treat
tunicamycin
presenc
tunicamycin
rate
synthesi
membran
glycoprotein
el
reduc
fig
channel
comparison
control
fig
channel
howev
clear
el
synthes
polypeptid
fig
channel
chase
glycosyl
form
fig
virion
observ
bud
plasma
membran
format
virion
inhibit
pgml
tunicamycin
fig
numer
virion
observ
dilat
cisterna
rer
smoothwal
vesicl
tunicamycintr
cell
although
virion
adsorb
plasma
membran
fig
virion
releas
tunicamycintr
cell
although
rgml
tunicamycin
reduc
yield
infecti
viru
looofold
larg
quantiti
virion
could
purifi
medium
sucros
densiti
gradient
ultracentrifug
number
virion
releas
tunicamycintr
cultur
fold
less
untreat
cultur
estim
electron
microscopi
virion
tunicamycintr
cell
lack
characterist
larg
peplom
coronavirus
fig
absenc
peplom
correl
inabl
virion
attach
receptor
cell
surfac
fig
initi
infect
structur
protein
virion
purifi
tunicamycintr
control
cultur
compar
fig
normal
viru
contain
el
n
three
form
glycoprotein
nativ
form
cleavag
product
highmolecularweight
aggreg
form
fig
contrast
viru
grown
tunicamycin
contain
el
n
normal
amount
complet
lack
peplomer
glycoprotein
fig
biochem
data
thu
confirm
ultrastructur
observ
absenc
peplom
virion
tunicamycintr
cell
el
membran
glycoprotein
viru
grown
tunicamycin
appear
glycosyl
normal
shown
ratio
glucosamin
methionin
label
el
peak
fig
b
confirm
observ
made
pulsechas
experi
fig
glycosyl
el
resist
inhibit
tunicamycin
fig
also
appar
ratio
glucosamin
methionin
label
constant
across
broad
peak
el
extens
glycosyl
correspond
decreas
electrophoret
mobil
oligosaccharid
chain
nand
olink
glycoprotein
differ
markedli
size
divers
carbohydr
composit
sharon
li
use
inform
oligosaccharid
obtain
analyz
glycopeptid
isol
glycoprotein
page
trisbor
buffer
weitzman
et
ak
alkalin
ph
neutral
sugar
form
neg
charg
complex
borat
number
borat
ion
react
glycopeptid
function
composit
sequenc
linkag
carbohydr
glycopeptid
dissimilar
carbohydr
composit
length
exhibit
differ
electrophoret
mobil
although
separ
glycopeptid
base
molecular
weight
gener
larger
oligosaccharid
bind
borat
smaller
one
therefor
migrat
faster
gel
differ
peptid
compon
appear
littl
effect
electrophoret
mobil
glycopeptid
thu
glycopeptid
two
differ
nlink
glycoprotein
would
expect
migrat
rather
similarli
wherea
glycopeptid
nand
olink
glycoprotein
would
differ
markedli
electrophoret
mobil
distribut
use
techniqu
compar
glycopeptid
deriv
pronas
digest
isol
el
figur
show
borat
complex
el
glycopeptid
exhibit
markedli
differ
electrophoret
pattern
glycopeptid
el
exhibit
significantli
greater
mobil
therefor
borateglycopeptid
complex
iijglucosaminelabel
glycoprotein
el
mhv
separ
sdspage
elut
gel
digest
pronas
hr
glycopeptid
lyophil
analyz
electrophoresi
polyacrylamid
gel
trisbor
buffer
ph
profil
shlglucosaminelabel
glycopeptid
el
b
shown
anod
right
el
significantli
neg
charg
figur
also
show
fewer
glycopeptid
compon
resolv
el
suggest
el
may
less
divers
oligosaccharid
side
chain
data
suggest
oligosaccharid
el
differ
markedli
support
hypothesi
oligosaccharid
el
may
deriv
differ
mechan
glycosyl
discuss
inhibit
glycosyl
structur
glycoprotein
alphavirus
leavitt
et
bunyavirus
cash
et
al
herp
virus
pizer
et
al
myxovirus
nakamura
compan
klenk
rott
paramyxovirus
stallcup
field
rhabdovirus
morrison
et
gibson
et
klenk
rott
retrovirus
schwarz
et
al
diggelman
suggest
virus
contain
nlink
glycoprotein
glycosyl
transfer
core
oligosaccharid
dolichol
pyrophosph
carrier
asparagin
residu
polypeptid
use
tunicamycin
often
permit
identif
nonglycosyl
protein
moieti
viral
glycoprotein
morrison
et
al
gibson
et
nakamura
compan
diggelman
viru
strain
howev
synthesi
nonglycosyl
polypeptid
presenc
tunicamycin
difficult
detect
complet
translat
glycoprotein
mrna
may
depend
cotransl
addit
nlink
oligosaccharid
chain
nonglycosyl
polypeptid
may
highli
suscept
degrad
host
cell
proteas
nonglycosyl
polypeptid
may
insolubl
schwarz
et
al
leavitt
et
al
gibson
et
diggelman
pizer
et
al
stallcup
field
coronaviru
mhv
contain
two
structur
glycoprotein
isol
partial
character
sturman
et
ak
cl
cell
infect
strain
mhv
tunicamycin
specif
interf
synthesi
peplomer
glycoprotein
fig
neither
glycosyl
nonglycosyl
form
detect
either
directli
immunoprecipit
suggest
like
viral
structur
glycoprotein
may
nlink
glycoprotein
transmembran
glycoprotein
el
mhv
far
uniqu
among
viral
structur
glycoprotein
glycosyl
presenc
tunicamycin
glycosyl
el
appear
posttransl
event
fig
shift
nonglycosyl
form
glycosyl
form
inhibit
tunicamycin
provid
indirect
evid
el
nlink
glycoprotein
may
olink
glycoprotein
hypothesi
also
support
direct
evid
concern
carbohydr
composit
oligosaccharid
side
chain
el
earli
studi
incorpor
radiolabel
sugar
el
show
el
label
shlglucosamin
label
hlfucos
sturman
holm
recent
studi
niemann
klenk
identifi
addit
differ
carbohydr
composit
el
el
like
cellular
olink
glycoprotein
thoma
winzler
spiro
bhoyroo
slomiani
slomiani
sharon
li
contain
littl
mannos
fucos
possess
high
proport
nacetyl
galactosamin
wherea
like
mani
nlink
glycoprotein
nakamura
compan
prehm
et
al
weitzman
et
ul
burk
keegstra
contain
mannos
fucos
nacetyl
galactosamin
oligosaccharid
el
remov
pelimin
h
niemann
hd
klenk
person
commun
although
size
linkag
sequenc
sugar
individu
oligosaccharid
chain
two
mhv
glycoprotein
yet
determin
analysi
oligopeptid
el
trisbor
page
shown
two
glycoprotein
distinct
oligosaccharid
side
chain
fig
techniqu
afford
resolut
compar
better
biogel
gel
filtrat
column
electrophoret
mobil
glycopeptid
similar
glycopeptid
nlink
glycoprotein
sindbi
viru
ovalbumin
previous
describ
weitzman
et
al
contrast
glycopeptid
el
neg
charg
thu
shown
el
differ
carbohydr
composit
electrophoreti
pattern
glycopeptid
respons
tunicamycin
data
suggest
nlink
glycoprotein
el
may
olink
glycoprotein
amino
acid
sequenc
locat
number
oligosaccharid
side
chain
mhv
glycoprotein
yet
known
howev
oligosaccharid
moieti
el
appear
locat
holm
doller
sturman
near
one
end
polypeptid
chain
treatment
mhv
virion
bromelain
pronas
remov
detach
glycosyl
polypeptid
el
leav
nonglycosyl
polypeptid
embed
within
viral
envelop
sturman
holm
sturman
yet
known
whether
glycosyl
portion
el
extend
outsid
viral
membran
contain
amino
termin
carboxi
termin
region
el
howev
region
appear
contain
multipl
oligosaccharid
side
chain
sinc
page
el
migrat
either
broad
diffus
band
condit
three
discret
band
role
glycosyl
function
el
yet
known
glycosyl
may
affect
conform
el
orient
viral
envelop
howev
glycosyl
el
may
essenti
virion
format
sinc
nonglycosyl
glycosyl
el
incorpor
virion
data
shown
ellik
membran
protein
found
coronavirus
appar
glycosyl
garw
novel
olink
posttransl
glycosyl
el
may
associ
restrict
intracellular
migrat
el
restrict
perinuclear
area
infect
cell
contrast
migrat
rapidli
plasma
membran
doller
holm
possibl
oligosaccharid
el
act
signal
movement
rer
membran
oligosaccharid
import
recognit
signal
enzym
destin
lysosom
hasilik
glycoprotein
destin
endocytosi
baenzig
fiet
stahl
schlesing
differenti
effect
tunicamycin
synthesi
glycosyl
two
coronaviru
envelop
glycoprotein
permit
tent
assign
function
glycoprotein
mhvinfect
cell
treat
tunicamycin
virion
lack
glycoprotein
henc
peplom
bud
intracytoplasm
membran
releas
cell
fig
thu
transmembran
glycoprotein
el
appear
envelop
glycoprotein
requir
viru
bud
inde
locat
el
intracytoplasm
membran
may
determin
bud
site
coronaviru
bud
may
occur
viral
nucleocapsid
recogn
intracellular
membran
alter
addit
el
glycoprotein
appearsto
essenti
viru
attach
receptor
plasma
membran
viru
lack
peplom
show
markedli
decreas
infect
virion
observ
adsorb
plasma
membran
tunicamycintr
cell
although
numer
virion
lack
present
medium
fig
mani
cellular
glycoprotein
fetuin
proteoglycan
glycophorin
thyroglobulin
immunoglobulin
contain
asparaginelink
serineor
threoninelink
oligosaccharid
sharon
li
detail
studi
may
reveal
olink
oligosaccharid
viral
glycoprotein
believ
contain
nlink
oligosaccharid
inde
vaccinia
viru
hemagglutinin
nonstructur
glycoprotein
nlink
oligosaccharid
chain
shida
dale
date
howev
structur
viral
glycoprotein
except
el
glycoprotein
mhv
identifi
might
contain
olink
carbohydr
unlik
glycosyl
el
virusencod
process
sinc
mhv
limit
amount
genet
materi
code
six
speci
mrna
siddel
et
al
rottier
et
far
like
glycosyl
el
occur
via
cellular
process
product
el
glycoprotein
may
good
model
system
studi
tunicamytinresist
glycosyl
mhvinfect
cell
treat
actinomycin
inhibit
synthesi
cellular
glycoprotein
tunicamycin
inhibit
synthesi
nlink
viral
glycoprotein
el
major
glycoprotein
synthes
glycoprotein
purifi
larg
amount
virion
releas
tunicamycintr
cell
thu
coronaviru
glycoprotein
el
may
use
model
analysi
synthesi
glycosyl
intracellular
transport
olink
glycoprotein
